Meet Cleanchem Laboratories at Pharmaconex – 01 September, 2026 to 03 September, 2026 • Booth / Stand: Hall 4, Stand #4B22 (Egypt International Exhibition Center, Cairo) – Book an in-person meeting with our scientific leadership team! •••
Details
Downloads
🇬🇧 EN English
🇸🇦 AR العربية
🇨🇳 CN 中文
🇫🇷 FR Français
🇯🇵 JP 日本語
🇵🇹 POR Português
🇷🇺 RU Русский
🇪🇸 ES Español
Compare Cart
ISO/IEC 17025 Accredited 21 CFR Part 11 Compliant Lab

Analytical Method Development & Validation

ISO/IEC 17025 accredited analytical method validation, forced degradation stress studies, and ultra-trace nitrosamine (NDSRI) detection.

WhatsApp Specialist
Analytical Method Development & Validation Laboratory Infrastructure
21 CFR Part 11 Compliant Lab
Typical Turnaround 2 - 3 Weeks (Complete Validation Protocol)
Scale & Capacity Analytical Sample Volumes
Purity Guarantee Sub-PPM Sensitivity Limit
Regulatory Standard ICH Q2(R1) & 21 CFR Part 11 Data Integrity

Technical Overview & Scientific Scope

Analytical Method Development & Validation Infrastructure & Cleanroom
Cleanchem R&D Facility Analytical Method Development & Validation • ISO 17025 & 17034 Accredited

Robust, stability-indicating analytical methods are foundational to modern pharmaceutical drug substance and drug product filings. Cleanchem Laboratories provides ISO/IEC 17025 and 21 CFR Part 11 compliant analytical method development, validation, and tech transfer services.

Our analytical team develops stability-indicating assays, dissolution testing protocols, and ultra-sensitive LC-MS/MS nitrosamine methods tailored to meet rigorous ICH Q2(R1) validation guidelines covering specificity, linearity, precision, accuracy, LOD/LOQ, and robustness.

Our analytical team develops stability-indicating assays, dissolution testing protocols, and ultra-sensitive LC-MS/MS nitrosamine methods tailored to meet rigorous ICH Q2(R1) validation guidelines covering specificity, linearity, precision, accuracy, LOD/LOQ, and robustness.

Cleanchem Quality & Regulatory Guarantee
Every synthesized molecule or isolated impurity standard is accompanied by an audit-ready regulatory release package compliant with ISO 17034 & ISO/IEC 17025 accreditation standards.

Core Scientific Capabilities

Specialized expertise engineered to resolve complex chemical challenges across target molecules:

ICH Q2(R1) Method Validation Protocols

Complete validation testing covering Specificity, Precision, Repeatability, Intermediate Precision, Accuracy, Range, and Solution Stability.

Ultra-Trace Nitrosamine (NDSRI) Testing

High-sensitivity LC-MS/MS and GC-MS/MS protocols quantifying genotoxic nitrosamines down to sub-ppm levels in line with FDA and EMA guidance.

Forced Degradation Stress Studies

Comprehensive stress testing under thermal, humidity, acid hydrolysis, base hydrolysis, oxidative (peroxide), and photolytic ICH Q1B conditions.

Multimedia Dissolution Testing

Comparative in vitro release profiles across pH 1.2, 4.5, 6.8, and bio-relevant media with statistical f1 (difference) and f2 (similarity) evaluation.

Process Workflow & Milestone Phases

Transparent, milestone-governed stage gate execution keeping your research program strictly on schedule:

Phase 01 Week 1

Method Feasibility & Specificity Scouting

Evaluating chromatographic columns, mobile phases, and gradient profiles to ensure baseline separation between API and all known impurities.

Phase 02 Week 2

Forced Degradation & Peak Purity Proof

Stress-testing the drug substance, demonstrating spectral homogeneity and mass balance using PDA and Q-TOF mass detectors.

Phase 03 Week 3

Full ICH Q2(R1) Method Validation Execution

Executing 6-analyst/multi-day validation runs verifying Linearity (r > 0.999), Accuracy (Recovery 98-102%), Repeatability, and Robustness.

Phase 04 Week 4

Validation Summary Report & Tech Transfer

Compilation of audit-proof validation dossier, raw data integration, electronic signatures, and method transfer SOP to sponsor laboratory.

Dedicated Analytical & Process Instrumentation

Our Navi Mumbai and Mahad testing facilities are equipped with qualified, 21 CFR Part 11 compliant hardware:

Instrument Platform Technical Specifications Primary Application
Agilent 1290 Infinity II UHPLC with DAD Operating pressures up to 1300 bar, sub-2 micron columns High-throughput stability-indicating method testing
AB Sciex Triple Quad 6500+ LC-MS/MS Sub-picogram sensitivity, MRM mode Ultra-trace NDSRI nitrosamine quantification
Agilent 7890B GC with Headspace Sampler FID & MS detectors, 7697A Headspace ICH Q3C Class 1, 2, 3 residual solvents testing
Electrolab 14-Vessel Dissolution Tester USP Apparatus 1 (Baskets) & 2 (Paddles) Multimedia comparative dissolution profile testing

Standard Documentation & Deliverables

Every project concludes with a complete regulatory package ready for instant DMF/ANDA regulatory submission:

ICH Q2(R1) Compliant Analytical Method Validation Report (AMVR)
Standard Operating Procedure (SOP) & Analytical Test Procedure (ATP)
Forced Degradation Stress Report with Mass Balance Balance Verification
Electronic Raw Data Package (Audit Trails, Chromatograms, Calibration Curves)
Certificate of Method Transfer & Inter-Laboratory Verification
ISO/IEC 17025 Laboratory Accreditation Endorsement

Frequently Asked Questions

Yes. All chromatography data systems (CDS) in Cleanchem laboratories operate with mandatory user authentication, role-based security, unalterable audit trails, and automated daily backups.
Pharmaconex

Let's connect at Pharmaconex

Cleanchem Laboratories successfully participates in Pharmaconex 2026 at the Egypt International Exhibition Center, engaging with pharmaceutical professionals from Egypt and across the region.

01 September, 2026 Booth Hall 4, Stand #4B22 Egypt International Exhibition Center, Cairo

Cleanchem Support Desk

Online • Scientific Support

👋 Hello! Welcome to Cleanchem Laboratories.

How can our senior analytical & synthesis team assist your project today?

Select an option: